A carregar...
PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking
Angiotensin-converting enzyme 2 (ACE2) is the binding-site and entry-point for SARS-CoV-2 in human and highly expressed in the lung. Cigarette smoking (CS) is the leading cause of pulmonary and cardiovascular diseases. Chronic CS leads to upregulation of bronchial ACE2 inducing a high vulnerability...
Na minha lista:
| Publicado no: | Biochem Pharmacol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Published by Elsevier Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7842152/ https://ncbi.nlm.nih.gov/pubmed/33515531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2021.114431 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|